Side-by-side comparison of AI visibility scores, market position, and capabilities
Wilmington DE specialty materials (NYSE: DD) at $12.4B 2024 revenue; Electronics business separation underway (semiconductor/advanced packaging materials), 2025 guidance $12.8-12.9B competing with Entegris and BASF.
DuPont de Nemours, Inc. is a Wilmington, Delaware-based specialty materials and chemicals company — publicly traded on the New York Stock Exchange (NYSE: DD) as an S&P 500 Materials component — providing advanced materials, specialty chemicals, and performance solutions for electronics, water treatment, safety applications, and industrial manufacturing through approximately 24,000 employees worldwide. In full year 2024, DuPont reported net sales of $12.4 billion (+3% year-over-year) and adjusted EPS of $4.07, with Q4 2024 net sales of $3.1 billion (+7%). For 2025, DuPont guided net sales of $12.8-12.9 billion with operating EBITDA of $3.325-3.375 billion. DuPont's defining strategic development of 2024-2025 is its announced separation into multiple independent companies: the Electronics business (semiconductor materials, advanced packaging materials, display technologies) is being separated as a standalone public company, targeting the multi-hundred-billion-dollar semiconductor materials market, while the remaining DuPont retains the Water & Protection and industrial specialty chemical businesses. This separation, when completed, will concentrate each business on its distinct end market — semiconductor advanced packaging materials (a high-growth AI chipmaking input) versus industrial protection and water purification applications. DuPont's heritage traces to 1802 when Éleuthère Irénée du Pont founded E.I. du Pont de Nemours to manufacture gunpowder, making it one of America's oldest continuously operating corporations.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.